Capital Analysts LLC’s Ambev ABEV Stock Holding History

Capital Analysts LLC’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-485	Closed	-$2K	–	694
2019 Q2	$2K	Buy	+485	New	+$2.17K	﹤0.01%	625

Other funds holding ABEV

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Capital Analysts LLC's ABEV Position: Q3 2019 in Review

Capital Analysts LLC sold out of Ambev (ABEV) in Q3 2019, closing a stake of 485 shares — an estimated $2K sold.

Capital Analysts LLC first reported a position in ABEV in Q2 2019 and held it in 1 quarter. The position peaked at $2K in Q2 2019. 294 funds tracked by Wall St. Rank hold ABEV as of Q3 2019.

Capital Analysts LLC reported no remaining Ambev position as of Q3 2019 after selling out during the quarter.
Capital Analysts LLC sold 485 Ambev shares in Q3 2019, an estimated $2K.
Capital Analysts LLC first reported a position in Ambev in Q2 2019 and held it in 1 quarter.
Capital Analysts LLC's Ambev position peaked at $2K in Q2 2019.
294 funds tracked by Wall St. Rank held Ambev as of Q3 2019.

Based on Capital Analysts LLC's 13F filing for Q3 2019, filed 12 Nov 2019.